The<unk> , a nonsteroidal antiandrogen (NSAA), including its frequent and rare side<unk> , have been well-studied and characterized. The most common<unk>  monotherapy in men include breast tenderness, gynecomastia, feminization, demasculinization, and hot flashes. Less common<unk>  monotherapy in men include sexual dysfunction, depression, fatigue, weakness, and anemia.<unk>  is well tolerated and has few side<unk>  in women. General<unk>  that may occur in either sex include diarrhea, constipation, abdominal pain, nausea, dry skin, itching, and rash. In men with prostate cancer,<unk>  monotherapy has been associated with an increased risk of non-cancer death, in part due to an increased incidence of heart failure. This is thought to be a consequence of androgen deprivation.<unk>  monotherapy has been found to cause unfavorable liver changes in around 3% of men, with such changes necessitating discontinuation in about 0.3 to 1% of men. Very rarely,<unk>  has been associated with liver damage, lung disease, and sensitivity to light. It has also uncommonly been associated with hypersensitivity reactions.<unk>  has a theoretical risk of birth defects in male fetuses.
Side effects of bicalutamide
Side effects of cyproterone acetate
Androgen insufficiency syndrome
Antiestrogen withdrawal response
Progestin-induced virilization
Hyperestrogenism
Androgen deficiency
Hormone-sensitive cancer